Last reviewed · How we verify
NCT07360522
Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting
trial testing Eko digital stethoscopes in Lung Diseases in 750 participants. Participants enrolled and being followed up; not accepting new ones.
21 July 2025
Quick facts
| Lead sponsor | Eko Devices, Inc. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 750 |
| Start date | 23 August 2024 |
| Primary completion | 21 July 2025 |
| Estimated completion | 15 March 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Eko digital stethoscopes
Conditions studied
- Lung Diseases — all drugs for Lung Diseases →
Sponsor
Eko Devices, Inc. — full company profile →
Who can join
18 and older, any sex, with Lung Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to collect patient lung sounds in order to develop an artificial machine learning algorithm that can potentially tell a doctor if a patient is at risk of certain lung conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07360522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Eko digital stethoscopes
Trials testing the same drug.
- NCT07270744 — Data Collection Using Eko Devices in a Clinical Setting · recruiting
- NCT07227376 — Data Collection Using Eko Digital Devices in a Clinical Setting · recruiting
- NCT07270692 — Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence · recruiting
Other recruiting trials for Lung Diseases
Currently open trials in the same condition.
- NCT07356076 — The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases · recruiting
- NCT07243964 — Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation · recruiting
- NCT07270744 — Data Collection Using Eko Devices in a Clinical Setting · recruiting
- NCT07227376 — Data Collection Using Eko Digital Devices in a Clinical Setting · recruiting
- NCT06917573 — PALACE: Cemiplimab Trial According to ctDNA Levels · Phase 2 · recruiting
Other Eko Devices, Inc. trials
Trials by the same sponsor.
- NCT07270744 — Data Collection Using Eko Devices in a Clinical Setting · recruiting
- NCT07227376 — Data Collection Using Eko Digital Devices in a Clinical Setting · recruiting
- NCT07270692 — Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence · recruiting
- NCT07136623 — Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope · recruiting
- NCT07087613 — Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07360522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eko Devices, Inc.
- Last refreshed: 22 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07360522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing